Evidence map›Paper›PMID 35663628›Full record

ArticleJACC. Basic to translational science2022

Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation: Implications for Coronary Artery Disease.

Dominik Rath, Vera Rapp, Jessica Schwartz, Stefan Winter, Frederic Emschermann, Daniel Arnold, Johannes Rheinlaender, Manuela Büttcher, Michael Strebl, Michael B Braun and 13 more

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Platelet versus plasma CXCL14, coronary artery disease, and clinical outcomes.Research and practice in thrombosis and haemostasis · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Dominik RathDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Vera RappDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Jessica SchwartzDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Stefan WinterDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Tübingen, Germany.
Frederic EmschermannDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Daniel ArnoldInstitute of Applied Physics, University of Tübingen, Tübingen, Germany.
Johannes RheinlaenderInstitute of Applied Physics, University of Tübingen, Tübingen, Germany.
Manuela BüttcherDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Michael StreblInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Michael B BraunInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Konstanze AltgeltDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Álvaro Petersen UribeDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Christoph SchoriesDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Denis CanjugaDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Elke SchaeffelerDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Tübingen, Germany.
Oliver BorstDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Tilman E SchäfferInstitute of Applied Physics, University of Tübingen, Tübingen, Germany.
Harald LangerDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Thilo StehleInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Matthias SchwabDr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Tübingen, Germany.
Tobias GeislerDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Meinrad GawazDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Madhumita ChatterjeeDepartment of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
University Children's Hospital Tübingen · DEUniversity of Tübingen · DEDr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic predisposition through

Indexed as

ACM, all-cause mortalityACS, acute coronary syndromeADP, adenosine diphosphateCAD, coronary artery diseaseCCS, chronic coronary syndromeCE, combined endpointcoronary artery diseaseHC, homozygous carriersIS, ischemic strokeJAM-AJAM-A, junctional adhesion molecule-AMI, myocardial infarctionplateletsJAM-A, soluble junctional adhesion molecule-AsmJAM-A, soluble murine junctional adhesion molecule-ASNVSNV, single-nucleotide variationthrombo-inflammationTRAP, thrombin receptor activating peptide

Identifiers

PMID35663628
PMCPMC9156439
OpenAlexW4281392920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.